Background and Purpose—Atherosclerosis is a diffuse, chronic inflammatory disorder that
involves the vascular, metabolic, and immune systems and leads to plaque vulnerability …

Intracerebral haemorrhage (ICH) still represents the most feared complication of
thrombolysis. Our aim was to review the literature regarding clinical, biological and imaging …

Background and Purpose—Herniation attributable to unilateral mass effect is the major
cause of death in cerebral venous thrombosis (CVT). Decompressive surgery may be …

Background and Purpose—The safety and the effectiveness of the surgical treatment of
spontaneous intracerebral hemorrhage (ICH) remain controversial. To investigate the …

Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and …

Background and Purpose—Intravenous tissue plasminogen activator improves outcome
after ischemic stroke when given within 3 hours of symptoms onset in carefully selected …

Background and Purpose—There has been speculation that the risk of secondary
symptomatic intracranial hemorrhage (SICH) may be increased after thrombolytic therapy in …

Background Patients who have had a stroke with unknown time of onset have been
previously excluded from thrombolysis. We aimed to establish whether intravenous …

Objective The risk for symptomatic intracerebral hemorrhage (sICH) associated with
thrombolytic treatment has not been evaluated in large studies using diffusion‐weighted …

Objectives To assess the efficacy and safety profile of stent-retriever thrombectomy (SRT) in
acute anterior ischemic stroke patients with tandem occlusion. Materials and methods Using …